Charles River raises profit forecast on growing demand for drug development services
The Wilmington, Massachusetts-based contract drug developer raised its 2025 adjusted profit forecast to $9.90 to $10.30 per share, compared with its previous projection of $9.30 to $9.80.
Contract research organizations, which reported quarterly results over the last month, have all posted better-than-expected profit, reflecting a rebound in spending from pharmaceutical and biotech clients after a cautious stretch driven by tighter sector financing.
Companies such as Danaher (DHR.N), opens new tab, Medpace <MEDP.O, IQVIA (IQV.N), opens new tab, ICON (ICLR.O), opens new tab and Thermo Fisher (TMO.N), opens new tab have posted strong results, owing to steady demand from the industry for tools and services used in the development of novel medicines.
"We are continuing to see clear signs that the biopharmaceutical demand is stabilizing, and in this environment, we are making gradual progress to return to organic revenue growth," Charles River CEO James Foster said.
The company now also expects its 2025 revenue to decline 0.5% to 2.5%, compared with its previous forecast of a 3.5% to 5.5% drop.
Charles River's second-quarter revenue came in at $1.03 billion, surpassing Wall Street estimates of $985.1 million, according to data compiled by LSEG.
The company reported quarterly profit of $3.12 per share on an adjusted basis, compared with analysts' average estimate of $2.50.
Separately, Charles River also said that the U.S. Fish and Wildlife Service had cleared its non-human primate (NHP) shipments from late 2022 and early 2023 for legal entry into the United States.
In 2023, the company suspended the shipment of NHPs from Cambodia as the Department of Justice and U.S. Fish and Wildlife Service investigated it over smuggling of wild long-tailed macaques to the U.S.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
37 minutes ago
- Reuters
Breakingviews - SoftBank throws Intel its next-best lifeline
HONG KONG, Aug 19 (Reuters Breakingviews) - Finally, some good news for Intel's (INTC.O), opens new tab beleaguered new boss. Since taking over the struggling chipmaker in March, Lip-Bu Tan has faced U.S. President Donald Trump's demands to step down, a credit-rating downgrade, deteriorating finances and other setbacks as he pushes ahead with an ambitious turnaround. Securing a $2 billion investment from Japan's SoftBank Group (9984.T), opens new tab is a much-needed endorsement. As part of the deal, opens new tab, Intel will issue new shares at a small discount to the stock's last close, giving Masayoshi Son's group an equity stake of just under 2%. The cash injection pales next to the $16.5 billion of capital expenditures Intel is forecast to make this year, per Visible Alpha, but at the very least, it should help bolster confidence. As recently as last month, Tan warned that Intel may be forced to exit the contract manufacturing business, where it has fallen behind Taiwan Semiconductor Manufacturing ( opens new tab and Samsung Electronics ( opens new tab, if it does not find a significant customer for its next-generation 14A manufacturing process. If that was a cry for help, the message has been well received. In addition to SoftBank, Intel may soon welcome another major shareholder: the Trump administration is in discussions to take a 10% stake in the company, Bloomberg reported, opens new tab on Monday, citing sources familiar with the plan, in a move that potentially speeds up the near-$11 billion in government grants promised to Intel as part of the 2022 CHIPS and Science Act. Having both Trump, who appears to have backed off his calls for Tan's resignation, and Son onboard could help the Intel boss. The White House might be able to exert pressure to help the executive mend a rift with his board about whether to spin out its manufacturing unit, as reported, opens new tab by the Wall Street Journal. And Son's bets in artificial intelligence, including the $500 billion Stargate Project, an AI infrastructure joint venture with OpenAI, might turn into a lucrative opportunity for Intel down the line. The problem is, what Intel really needs is to revive sales now. That's unlikely to happen: SoftBank will neither seek a board seat nor commit to buying Intel's chips, according to Reuters, citing a source. Realistically, only a strategic investor committed to Intel's long-term technological progress can reverse its decline. That would require, say, an Nvidia (NVDA.O), opens new tab or AMD (AMD.O), opens new tab deciding they need to support alternative high-end chip manufacturers to TSMC. Until then, Tan will have to make do. Follow Robyn Mak on X, opens new tab.
Reuters
2 hours ago
- Reuters
South Korea's Lee meets business leaders to discuss summit with Trump
SEOUL, Aug 19 (Reuters) - South Korean President Lee Jae Myung met on Tuesday the leaders of some of the country's biggest conglomerates who will accompany Lee to Washington for his summit next week with U.S. President Donald Trump, Lee's office said. Lee and Trump will hold their first summit meeting on August 25 to discuss strengthening the countries' alliance and economic security partnership, including advancing a partnership in the manufacturing sector based on a tariff deal reached last month, Lee's office said previously. Trump said last month the U.S. would charge a 15% tariff on South Korean imports as part of a deal to avoid even higher levies, while Seoul would invest $350 billion in his country. Uncertainties remain, however, since there was no written agreement, including over how the fund might work in practice and whether defence costs are brought in given how Trump has long called for Seoul to pay more for the U.S. troop presence. The business leaders meeting Lee on Tuesday represent industries seen as key to negotiations in advancing manufacturing ties with the U.S., coming from sectors such as chips, shipbuilding, automobiles, defence, pharmaceuticals and energy. Samsung Electronics Chairman Jay Y. Lee, SK Group Chairman Chey Tae-won, LG Group Chairman Koo Kwang-mo and executives from businesses such as Hyundai Motor Group, Hanwha Group and others were due to attend the meeting ahead of the trip to Washington. Lee is expected to thank the business leaders for their assistance in reaching the tariff deal with the U.S. and seek their continued help in detailed negotiations around the summit, the Yonhap News Agency reported.
Reuters
2 hours ago
- Reuters
S&P affirms US 'AA+' credit rating, cites tariff revenue
Aug 18 (Reuters) - S&P Global on Monday affirmed its 'AA+' credit rating on the U.S., saying the revenue from President Donald Trump's tariffs will offset the fiscal hit from his recent tax-cut and spending bill. Trump signed the massive package of tax-cut and spending bill, dubbed the 'One Big Beautiful Bill Act', into law in July. The bill, which delivered new tax breaks, also made Trump's 2017 tax cuts permanent. "Amid the rise in effective tariff rates, we expect meaningful tariff revenue to generally offset weaker fiscal outcomes that might otherwise be associated with the recent fiscal legislation, which contains both cuts and increases in tax and spending," S&P said in a statement. "At this time, it appears that meaningful tariff revenue has the potential to offset the deficit-raising aspects of the recent budget legislation." The U.S. reported a $21 billion jump in customs duty collections from Trump's tariffs in July but the government budget deficit still grew nearly 20% in the same month to $291 billion. Since returning to power in January this year, Trump has launched a global trade war with a range of tariffs that have targeted individual products and countries. The president has set a baseline tariff of 10% on all imports to the United States, as well as additional duties on certain products or countries. S&P said the outlook on the U.S. rating remains stable. The ratings agency expected the Federal Reserve, which Trump has often criticized for not cutting rates fast, "to navigate the challenges of lowering domestic inflation and addressing financial market vulnerabilities." It projected the country's general government deficit to average 6.0% of GDP during the 2025-2028 period, down from the 7.5% in 2024, and from an average 9.8% of GDP in 2020-2023. Peer Moody's downgraded the U.S. sovereign debt rating in May citing rising debt.
